Buy (150 RUB)
Generate QR code
Open Access
Subscription or Fee Access
Antibacterial, probiotic and immunomodulatory properties of L. acidophilus La‑14
https://doi.org/10.33667/2078-5631-2023-29-62-66
Abstract
Many scientific studies show the preventive and therapeutic effects of probiotics in various diseases. The L. acidophilus La‑14 strain has proven antibacterial, probiotic and immunomodulatory effectiveness, has a long history of use and does not cause the development of antibiotic resistance. Further research is needed to determine the optimal dose and duration of probiotic intake.
About the Authors
S. V. Orlova
Peoples’ Friendship University of Russia named after Patrice Lumumba; Scientific and Practical Center for Pediatric Psychoneurology of the Moscow Department of Health
Russian Federation
Russian Federation
Orlova Svetlana V., DM Sci (habil.), professor, head of Dept of Dietetics and Clinical Nutritiology; Chief Researche
Moscow
Е. А. Nikitina
Peoples’ Friendship University of Russia named after Patrice Lumumba; Scientific and Practical Center for Pediatric Psychoneurology of the Moscow Department of Health
Russian Federation
Russian Federation
Nikitina Elena A., PhD Med, assistant professor of Dept of Dietetics and Clinical Nutritiology; Researcher
Moscow
V. I. Popadyuk
Peoples’ Friendship University of Russia named after Patrice Lumumba
Russian Federation
Russian Federation
Popadyuk Valentin I., DM Sci (habil.), professor, dean of FNMO Faculty, Head of the Department of Otorhinolaryngology of the Medical Institute
Moscow
N. V. Kuznetsova
Peoples’ Friendship University of Russia named after Patrice Lumumba
Russian Federation
Russian Federation
Kuznetsova Nadezhda V., postgraduate student of the Dept of
Otorhinolaryngology of the Medical Institute
Moscow
I. M. Kirichenko
Peoples’ Friendship University of Russia named after Patrice Lumumba; International Medical Center On Clinics
Russian Federation
Russian Federation
Kirichenko Irina M., DM Sci (habil.), professor of the Dept of Otorhinolaryngology of the Medical Institute; head of the Dept of Otorhinolaryngology
Moscow
References
1. FAO/WHO Food and Agriculture Organization of the United Nations/World Health Organization Guidelines for the Evaluation of Probiotics in Food. [(accessed on 21 November 2020)]; Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. 2002 Available online: https://www.who.int/foodsafety/fs_management/en/ probiotic_guidelines.pdf.
2. Technical Regulations of the Customs Union TR CU 033/2013 “On the safety of milk and dairy products.” Adopted by the Decision of the Council of the Eurasian Economic Commission dated October 9, 2013 N 67. https://docs. cntd.ru/document/499050562
3. Unified sanitary-epidemiological and hygienic requirements for products (goods) subject to sanitary-epidemiological supervision (control) (approved by the Decision of the Commission of the Customs Union dated May 28, 2010 No. 299). https://eec.eaeunion.org/commission/department/depsanmer/ regulation/P2_299.php
4. Technical Memorandum Lactobacillus acidophilus La 14. Danisco. http://03a5bcb.netsolstores.com/images/research/Lacidophilus.pdf
5. Schlievert PM, Gaitán AV, Kilgore SH, Roe AL, Maukonen J, Lehtoranta L, Leung DYM, Marsman DS. Inhibition of Toxic Shock Syndrome-Associated Staphylococcus aureus by Probiotic Lactobacilli. Microbiol. Spectr. 2023 Aug 17; 11 (4): e0173523. DOI: 10.1128/spectrum.01735–23
6. De Alberti D, Russo R, Terruzzi F, Nobile V, Ouwehand AC. Lactobacilli vaginal colonisation after oral consumption of Respecta(®) complex: a randomised controlled pilot study. Arch. Gynecol. Obstet. 2015 Oct; 292 (4): 861–7. DOI: 10.1007/s00404–015–3711–4
7. Russo R, Edu A, De Seta F. Study on the effects of an oral lactobacilli and lactoferrin complex in women with intermediate vaginal microbiota. Arch. Gynecol. Obstet. 2018 Jul; 298 (1): 139–145. DOI: 10.1007/s00404–018–4771-z
8. Russo R, Karadja E, De Seta F. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial. Benef. Microbes. 2019 Feb 8; 10 (1): 19–26. DOI: 10.3920/BM2018.0075
9. Russo R, Superti F, Karadja E, De Seta F. Randomised clinical trial in women with Recurrent Vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment. Mycoses. 2019 Apr; 62 (4): 328–335. DOI: 10.1111/myc.12883
10. Del Popolo G, Nelli F. Recurrent bacterial symptomatic cystitis: A pilot study on a new natural option for treatment. Arch. Ital. Urol. Androl. 2018 Jun 30; 90 (2): 101–103.
11. Luo, X.Y., Lun, Y.Z„ Gao, W„ Hu, H.B., Wang, Q., Liu, Y., Yin, J.S.& Jiang, S. J. Effects of spent culture supernatant of Lactobacillus acidophilus on intestinal flora in mice with antibiotic- associated diarrhoea. Shijie Huaren Xiaohua Zazhi. 2006; 14 (19): 1870–1873. DOI: 10.11569/wcjd.v14.i19.1870
12. Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2019 Apr 30; 4 (4): CD004827. DOI: 10.1002/14651858.CD004827.pub5
13. Elawadli I, Brisbin JT, Mallard BA, Griffiths MW, Corredig M, Sharif S. Differential effects of lactobacilli on activation and maturation of mouse dendritic cells. Benef. Microbes. 2014 Sep; 5 (3): 323–34. DOI: 10.3920/BM2013.0066
14. Paineau D, Carcano D, Leyer G, Darquy S, Alyanakian MA, Simoneau G, Bergmann JF, Brassart D, Bornet F, Ouwehand AC. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol. Med. Microbiol. 2008 Jun; 53 (1): 107–13. DOI: 10.1111/j.1574–695X.2008.00413.x
15. Galdeano CM, Perdigón G. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J. Appl. Microbiol. 2004; 97 (4): 673–81. DOI: 10.1111/j.1365–2672.2004.02353.x
16. Paineau D, Carcano D, Leyer G, Darquy S, Alyanakian MA, Simoneau G, Bergmann JF, Brassart D, Bornet F, Ouwehand AC. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol. Med. Microbiol. 2008 Jun; 53 (1): 107–13. DOI: 10.1111/j.1574–695X.2008.00413.x
17. Forssten S, Ouwehand AC. Dose-Response Recovery of Probiotic Strains in Simulated Gastro-Intestinal Passage. Microorganisms. 2020 Jan 13; 8 (1): 112. DOI: 10.3390/microorganisms8010112
18. Hong Chau TT, Minh Chau NN, Hoang Le NT, Chung The H, Voong Vinh P, Nguyen To NT, Ngoc NM, Tuan HM, Chau Ngoc TL, Kolader ME, Farrar JJ, Wolbers M, Thwaites GE, Baker S; Oxford-Vietnam Probiotics Study Group. A Double-blind, Randomized, Placebo-controlled Trial of Lactobacillus acidophilus for the Treatment of Acute Watery Diarrhea in Vietnamese Children. Pediatr. Infect. Dis. J. 2018 Jan; 37 (1): 35–42. DOI: 10.1097/INF.0000000000001712
19. Todorov SD, Furtado DN, Saad SM, Gombossy de Melo Franco BD. Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La 14, a potential probiotic strain. New Microbiol. 2011 Oct; 34 (4): 357–70. Epub 2011 Oct 31. PMID: 22143809
20. Lazebnik L. B., Golovanova E. V., Turkina S. V., Raikhelson K. L., Okovityy S. V., Drapkina O.M., Maev I. V., Martynov A. I., Roitberg G. E., Khlynova O. V., Abdulganieva D.I., Alekseenko S.A., Ardatskaya M.D., Bakulin I.G., Bakulina N.V., Bueverov A.O., Vinitskaya E. V., Volynets G.V., Eremina E. Yu., Grinevich V.B., Dolgushina A. I., Kazyulin A. N., Kashkina E. I., Kozlova I. V., Konev Yu.V., Korochanskaya N. V., Kravchuk Yu.A., Li E. D., Loranskaya I. D., Makhov V. M., Mekhtiev S. N., Novikova V. P., Ostroumova O. D., Pavlov Ch.S., Radchenko V.G., Samsonov A.A., Sarsenbaeva A. S., Sayfutdinov R.G., Seliverstov P.V., Sitkin S. I., Stefanyuk O. V., Tarasova L. V., Tkachenko E. I., Uspensky Yu.P., Fominykh Yu.A., Khavkin A.I., Tsyganova Yu.V., Sharhun O.O. Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version. Experimental and Clinical Gastroenterology. 2021; 1 (1): 4–52. (In Russ.) https://doi.org/10.31146/1682–8658-ecg 185–1–4–52
21. World Gastroenterology Organisation Global Guidelines ‘Probiotics and Prebiotics’. 2017 Feb. Available at: https://www.worldgastroenterology.org/ UserFiles/file/guidelines/probiotics-and-prebiotics-english 2017.pdf
22. Perna S, Ilyas Z, Giacosa A, Gasparri C, Peroni G, Faliva MA, Rigon C, Naso M, Riva A, Petrangolini G, A Redha A, Rondanelli M. Is Probiotic Supplementation Useful for the Management of Body Weight and Other Anthropometric Measures in Adults Affected by Overweight and Obesity with Metabolic Related Diseases? A Systematic Review and Meta-Analysis. Nutrients. 2021 Feb 19; 13 (2): 666. DOI: 10.3390/nu13020666
23. Nikitina E.A., Orlova S.V., Orlova A.A. Probiotics: present and future. Medical alphabet. 2021; 21: 101–114. https://dloi.org/10.3366772078–5631–2021–21– 101–114
24. Bendazzoli C, Turroni S, Gotti R, Olmo S, Brigidi P, Cavrini V. Determination of oxalyl-coenzyme A decarboxylase activity in Oxalobacter formigenes and Lactobacillus acidophilus by capillary electrophoresis. J. Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jul 1; 854 (1–2): 350–6. DOI: 10.1016/j. jchromb.2007.04.027
25. Turroni S, Vitali B, Bendazzoli C, Candela M, Gotti R, Federici F, Pirovano F, Brigidi P. Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus. J. Appl. Microbiol. 2007 Nov; 103 (5): 1600–9. DOI: 10.1111/j.1365– 2672.2007.03388.x
Review
For citations:
Orlova S.V., Nikitina Е.А., Popadyuk V.I., Kuznetsova N.V., Kirichenko I.M. Antibacterial, probiotic and immunomodulatory properties of L. acidophilus La‑14. Medical alphabet. 2023;(29):62-66. (In Russ.) https://doi.org/10.33667/2078-5631-2023-29-62-66
Views:
935
Email this article 